Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...

Background: The presence of infective microorganisms in the bilio-pancreatic tract is believed to be important in both the onset and outcome of acute biliary pancreatitis. In this study ...

THERE have been few fundamental contributions to the diagnosis and management of biliary-tract disease in recent years, but a current evaluation of the subject is justified in view of the large ...

Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well ...

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal of Clinical Oncology show that chemotherapy combining three different ...

Bile reflux gastritis (BRG) is a gastro-intestinal condition especially characterized by the reflux of bile into the stomach, further leading to mucosal inflammation along with various other clinical ...

The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.

Gallbladder cancer is a highly aggressive condition with vague symptoms, often leading to late diagnosis. Risk factors ...

The following is a summary of “Collagen turnover biomarkers to predict outcome of patients with biliary cancer,” published in ...

Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

Eisai has filed for approval in Japan for tasurgratinib, its small-molecule fibroblast growth factor (FGF) receptor inhibitor, as a treatment for biliary tract cancers with FGFR2 gene fusion ...